If trials on humans go the way they did on rats and pigs, a stem cell therapy to treat patients with Lou Gehrig’s disease could be on the market in four years…
Human stem cell therapy could be on market in four years, researcher says
Oct 5, 2010
Recent Posts
- Treating spinal cord injuries with stem cells
- New CRISPR tool enables more seamless gene editing — and improved disease modeling
- Building a regenerative medicine industry: Lessons from North Carolina
- Healthspan Action Coalition and Kitalys Institute Propose Landmark Legislation to Promote Healthy Longevity
- Probing the Mysteries of the Aging Brain
- Cells That Build Themselves Into an Embryo? Scientists Just Made It Happen